0.68 - 0.75
0.33 - 0.86
12.80M / 4.66M (Avg.)
35.00 | 0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-30.24%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-24.76%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
46.87%
EBIT growth above 1.5x 0425.HK's 10.77%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
46.87%
Operating income growth above 1.5x 0425.HK's 10.77%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
-112.51%
Negative net income growth while 0425.HK stands at 32.49%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-112.61%
Negative EPS growth while 0425.HK is at 32.20%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-114.85%
Negative diluted EPS growth while 0425.HK is at 32.20%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-1.05%
Share reduction while 0425.HK is at 0.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-14.84%
Reduced diluted shares while 0425.HK is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-146.12%
Negative OCF growth while 0425.HK is at 23.36%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-96.66%
Negative FCF growth while 0425.HK is at 501.46%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
-33.83%
Negative 10Y revenue/share CAGR while 0425.HK stands at 301.08%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-41.53%
Negative 5Y CAGR while 0425.HK stands at 85.78%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-33.91%
Negative 3Y CAGR while 0425.HK stands at 42.33%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
-2026.74%
Negative 10Y OCF/share CAGR while 0425.HK stands at 264.25%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
-330.94%
Negative 5Y OCF/share CAGR while 0425.HK is at 182.29%. Joel Greenblatt would question the firm’s operational model or cost structure.
-107.08%
Negative 3Y OCF/share CAGR while 0425.HK stands at 39.25%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
-102.98%
Negative 10Y net income/share CAGR while 0425.HK is at 126.01%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-105.81%
Negative 5Y net income/share CAGR while 0425.HK is 51.86%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-104.20%
Negative 3Y CAGR while 0425.HK is 7.18%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
631.56%
10Y equity/share CAGR above 1.5x 0425.HK's 228.30%. David Dodd would confirm if consistent earnings retention or fewer write-downs drive this advantage.
14.54%
Below 50% of 0425.HK's 67.71%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
19.89%
3Y equity/share CAGR at 50-75% of 0425.HK's 36.47%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
-92.85%
Cut dividends over 10 years while 0425.HK stands at 775.75%. Joel Greenblatt suspects a weaker ability to return capital vs. the competitor.
-19.58%
Negative 5Y dividend/share CAGR while 0425.HK stands at 61.75%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
-39.20%
Negative near-term dividend growth while 0425.HK invests at 24.93%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-22.12%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
23.92%
We show growth while 0425.HK is shrinking stock. John Neff wonders if the competitor is more disciplined or has weaker demand expectations.
-8.19%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
1.51%
Under 50% of 0425.HK's 3.14%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
38.08%
We have some new debt while 0425.HK reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-67.10%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-20.20%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.